The state of California wants to revoke or suspend the wholesale license for a facility run by AmerisourceBergen (ABC), one of the nation’s largest pharmaceutical distributors, for failing to note patterns of unusual sales of opioid painkillers and other controlled substances shipped to different pharmacies over a number of years.

Between 2008 and 2014, the facility based in Sacramento, Calif., sold large quantities of such medicines as Norco, which is a mixture of acetaminophen and hydrocodone; oxycodone; and promethazine with codeine syrup to four different pharmacies, according to a May 30 complaint filed by the state Board of Pharmacy. The complaint was made public on the agency website last week.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy